Guru Ownership Trend
Guru Analysis for United Therapeutics Corporation (UTHR)
United Therapeutics Corporation (UTHR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 11 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.36 B.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bearish. This is evidenced by a $158.36 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Cliff Asness reduced exposure by 33.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for United Therapeutics Corporation (UTHR)
Major holders include Renaissance Technologies (RenTech) ($925.85 M), Cliff Asness ($294.64 M), Steven Cohen ($108.99 M). According to the latest reported data, 11 tracked investment managers collectively hold approximately 2.7 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $158.36 M, with 6 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 5 managers trimmed their positions, while 1 fully exited UTHR. The total reported sell value was $194.93 M.
Yes, 3 managers opened new positions in UTHR, and 3 increased their existing holdings. The total reported buy value was $36.56 M.
